ArticleJournal of gastrointestinal cancer2026
The Natural History and Prognostic Determinants of Untreated Hepatocellular Carcinoma in a Sub-Saharan African Cohort.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hepatocellular Carcinoma in Africa: Epidemiology, Prevention and Outcomes.Current hepatology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData on the natural history of untreated hepatocellular carcinoma (HCC) are limited and derive mostly from patients in untreated arms of randomised control trials, conducted in high income countries. In this study, we determined the natural history of untreated HCC and identify predictors of survival in a predominantly SSA cohort of patients managed at Groote Schuur Hospital, Cape Town, South Africa.
methodsA 35-year retrospective cohort study of 469 patients with untreated HCC managed at Groote Schuur Hospital, Cape Town, South Africa from 1990 to 2025 was conducted. Demographics, clinical features, laboratory data, radiological findings and survival were analysed. Multivariate Cox regression identified independent predictors of mortality.
resultsThe cohort comprised 347 (74%) men, with a median age of 48 [19–89] years. The majority (380/469, 81.0%) were from South Africa, while the remaining 89 patients originated mostly from other neighbouring SSA countries. Chronic hepatitis B virus (HBV) infection was the leading aetiology (53.3%). Most (96.3%) presented with advanced disease (BCLC stage C or D), with high rates of multifocal tumours (69.1%), portal vein tumour thrombosis (38.8%) and extrahepatic metastases (32.6%). The median overall survival was 36.5 days and the one, six and 12-month survival rates were 59.8%, 14.4% and 7.6% respectively. Independent predictors of mortality included poor performance status, elevated alpha-fetoprotein levels, hypoalbuminemia, higher CTP grade, elevated MELD-Na and advanced BCLC stage.
conclusionUntreated HCC in sub-Saharan Africa is marked by advanced presentation and aggressive disease with rapid clinical deterioration and poor long-term survival. This study highlights the critical need for earlier diagnosis, HBV prevention and the development of accessible, early context-appropriate palliative care interventions in resource-limited settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.